Brain tumor requires combination therapy

21-01-2019

Malignant brain tumors respond very poorly to treatment because of uncontrolled cell proliferation, strong invasiveness and resistance to therapy.

PhD researcher Mark de Gooijer has shown that, although new treatments can efficiently attack each of these problems separately, combining them will be necessary to provide better prognoses for patients with brain tumors. On Wednesday he will defend his thesis. Good Luck Mark!

When: Wednesday January 23^rd, 2.30 PM

Where: Academiegebouw, Domplein 29, 3512 JE Utrecht

Thesis title: Mounting an attack on the glioblastoma triad: proliferation, invasion and resistance.

More information about the defense.

Brain tumor requires combination therapy

This site uses cookies